Why the study?
The mechanisms governing the subcellular localization of the PKA catalytic subunit during β-adrenergic signaling in the heart remain unclear. Extended synaptotagmin-1 has been associated with compartmentalization signals, prompting investigation into whether it modulates β-adrenergic signaling and cardiac contractility by coordinating PKAc localization and activity.
Does extended synaptotagmin-1 (E-Syt1) modulate β-adrenergic signaling and isoproterenol-induced cardiac contractility by interacting with protein kinase A catalytic subunit (PKAc) in mice?
Does extended synaptotagmin-1 (E-Syt1) modulate β-adrenergic signaling and isoproterenol-induced cardiac contractility by interacting with protein kinase A catalytic subunit (PKAc) in mice?
E-Syt1 forms a signaling complex with PKAc via its SMP domain to facilitate localized CaV1.2 phosphorylation and myocardial contractility during β-adrenergic stimulation, representing a novel regulator of cardiac cAMP/PKA microdomains.
Answers are grounded in this paper and cite their sources.
E-Syt1 knockout abolishes β-adrenergic responses in mice; hypothesis-generating for PKA compartmentalization in human heart failure.
Sympathetic activation of the heart enhances myocardial contractility via the β-adrenergic receptor/adenylate cyclase/cAMP/PKA signaling pathway. Although Protein Kinase A Catalytic Subunit (PKAc) mediates downstream protein phosphorylation, the mechanisms governing its subcellular localization remain unclear. Extended synaptotagmin-1 (E-Syt1), a stress-activated membrane tethering protein located at endoplasmic reticulum-plasma membrane (ER-PM) contact sites, has been associated with compartmentalization signals. This study aimed to investigate whether E-Syt1 modulates β-adrenergic signaling and cardiac contractility by coordinating the localization and activity of PKAc. Mice were injected the β-adrenergic agonist isoproterenol (ISO), and cardiac function was evaluated by echocardiography in E-Syt1 knockout (E-Syt1-/-) and wild-type mice. E-Syt1 knockout mice exhibit reduced cardiac contractility after ISO treatment. Despite gene expression of the β-adrenergic pathway was not altered, ISO stimulation in E-Syt1-/- hearts resulted in reduced cytosolic cAMP levels and decreased phosphorylation of Cav1.2. LC-MS/MS and immunofluorescence verified the interaction between E-Syt1 and PKAc. Rescue experiments highlighted the critical role of E-Syt1-PKAc in mediating Cav1.2 phosphorylation through the SMP domain interactions. E-Syt1 regulates Cav1.2 phosphorylation by forming a signaling complex with PKAc, supporting efficient β-adrenergic signaling.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied Sympathetic stimulation / β-adrenergic signaling and cardiac contractility. Extended synaptotagmin-1 (E-Syt1) knockout (E-Syt1-/-) and intraperitoneal isoproterenol (ISO) stimulation vs. Wild-type C57BL/6 mice and equal volume of saline control was evaluated on Myocardial contractility (left ventricular ejection fraction [LVEF] and fractional shortening [LVFS] via M-mode echocardiography) and intracellular cAMP/CaV1.2 Ser1928 phosphorylation.
Synapse has enriched 10 related papers. Consider them for comparative context: